Holland & Knight Advises Locatel on Cannabis Partnership with Khiron Life Sciences Group
BOGOTÁ (May 5, 2020) – Holland & Knight advised Locatel, a pharmacy, healthcare products and medical equipment retailer with more than 2 million patients in Colombia, in a sales and distribution agreement with Khiron Life Sciences Corp. Khiron is a leading cannabis company with core operations in Latin America and Europe. The deal, which immediately brings Khiron's medical cannabis products to Locatel's pharmacies and medical equipment stores in Bogotá and Cartagena, closed on April 22.
Khiron (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC) is the dominant integrated medical cannabis company in Latin America. The company has core operations in Latin America, along with activity in North America and Europe, and is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.
Locatel's operations are deemed an essential service in Colombia during the COVID-19 pandemic, ensuring continued access to filling and delivery of prescriptions.
Holland & Knight Partner Danilo Romero Raad advised Locatel in the agreement. He was assisted by Associate María Isabel Romero and Partner Lucas Saffon.